Systemic oxaliplatin or in intra-arterial chemotherapy combined with LV5FU2 +/- Irinotecan and targeted therapy in first-line treatment of metastatic colorectal cancer restricted to the liver

ABSTRACT: Primary objectives: Comparison of radiological and/or clinical progression free survival between the arm with intraarterial oxaliplatin administration (Arms A and C) and those with intravenous oxaliplatin administration (Arms B and D). Progression was assessed according to the criteria RECIST v1.1 and according to the investigator. Primary endpoints: Progression free survival (median)

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Cancer With Hepatic Metastasis,Colorectal Cancer Metastatic,Cancer Colorectal Métastatique Au Niveau Hépatique

PROVIDER: 2744502 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR